The COMPASS Study: A Study of Volanesorsen (Formally ISIS-APOCIIIRx) in Patients With Hypertriglyceridemia
Public ClinicalTrials.gov record NCT02300233. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The COMPASS Study: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of ISIS 304801 Administered Subcutaneously to Patients With Hypertriglyceridemia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy and safety of volanesorsen given for 26 weeks in participants with Hypertriglyceridemia.
Study identification
- NCT ID
- NCT02300233
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 114 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 5, 2015 (Actual)
- Primary completion
- Jul 27, 2016 (Actual)
- Completion
- Jan 24, 2017 (Actual)
- Last update posted
- Apr 13, 2022
2015 – 2017
United States locations
- U.S. sites
- 29
- U.S. states
- 17
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| IONIS Investigative Site | Encinitas | California | 92024 | — |
| IONIS Investigative Site | San Francisco | California | 94143 | — |
| IONIS Investigative Site | Boca Raton | Florida | 33434 | — |
| IONIS Investigative Site | Miami | Florida | 33147 | — |
| IONIS Investigative Site | Sterling | Illinois | 61081 | — |
| IONIS Investigative Site | Kansas City | Kansas | 66160 | — |
| IONIS Investigative Site | Salisbury | Maryland | 73103 | — |
| IONIS Investigative Site | Towson | Maryland | 21204 | — |
| IONIS Investigative Site | Boston | Massachusetts | 02114 | — |
| IONIS Investigative Site | Grandville | Michigan | 49418 | — |
| IONIS Investigative Site | North Massapequa | New York | 11758-1802 | — |
| IONIS Investigative Site | Benson | North Carolina | 27504 | — |
| IONIS Investigative Site | Chapel Hill | North Carolina | 27609 | — |
| IONIS Investigative Site | Farmville | North Carolina | 27828 | — |
| IONIS Investigative Site | Greenville | North Carolina | 27834 | — |
| IONIS Investigative Site | Morrisville | North Carolina | 27560 | — |
| IONIS Investigative Site | Raleigh | North Carolina | 27612 | — |
| IONIS Investigative Site | Wilson | North Carolina | 27609 | — |
| IONIS Investigative Site | Wilson | North Carolina | 27893 | — |
| IONIS Investigative Site | Cincinnati | Ohio | 45227 | — |
| IONIS Investigative Site | Kettering | Ohio | 45429 | — |
| IONIS Investigative Site | Marion | Ohio | 43302 | — |
| IONIS Investigative Site | Oklahoma City | Oklahoma | 73103 | — |
| IONIS Investigative Site | Portland | Oregon | 97239 | — |
| IONIS Investigative Site | Providence | Rhode Island | 02906 | — |
| IONIS Investigative Site | Houston | Texas | 77030 | — |
| IONIS Investigative Site | Salt Lake City | Utah | 84108 | — |
| IONIS Investigative Site | Norfolk | Virginia | 23510 | — |
| IONIS Investigative Site | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02300233, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 13, 2022 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02300233 live on ClinicalTrials.gov.